BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29037813)

  • 1. Fluorescence-labeled liposome accumulation in injured colon of a mouse model of T-cell transfer-mediated inflammatory bowel disease.
    Yamasaki M; Muraki Y; Nishimoto Y; Murakawa Y; Matsuo T
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):188-193. PubMed ID: 29037813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent Imaging Analysis for Distribution of Fluorescent Dye Labeled- or Encapsulated-Liposome in Monocrotaline-Induced Pulmonary Hypertension Model Rat.
    Muraki Y; Yamasaki M; Takeuchi H; Tohyama K; Sano N; Matsuo T
    Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):270-276. PubMed ID: 29311495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of liposomes for colon targeted drug delivery.
    Gupta AS; Kshirsagar SJ; Bhalekar MR; Saldanha T
    J Drug Target; 2013 Feb; 21(2):146-60. PubMed ID: 23373543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of PEG-liposomes in the inflamed colon of rats: potential for therapeutic and diagnostic targeting of inflammatory bowel diseases.
    Awasthi VD; Goins B; Klipper R; Phillips WT
    J Drug Target; 2002 Aug; 10(5):419-27. PubMed ID: 12442813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effect of liposomes loaded with chlorogenic acid in treatment of 2,4,6-trinitrobenzenesulfonic acid-induced murine colitis.
    Krajewska JB; Pietruszka P; Tomczyk D; Chen C; Owczarek A; Karolewicz B; Czapor-Irzabek H; Gorniak A; Fichna J
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31443089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-MSH Targeted Liposomal Nanoparticle for Imaging in Inflammatory Bowel Disease (IBD).
    Peñate-Medina T; Damoah C; Benezra M; Will O; Kairemo K; Humbert J; Sebens S; Peñate-Medina O
    Curr Pharm Des; 2020; 26(31):3840-3846. PubMed ID: 32718282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-Mediated Drug Delivery in Larval Zebrafish to Manipulate Macrophage Function.
    Wu Z; Koh B; Lawrence LM; Kanamala M; Pool B; Svirskis D; Dalbeth N; Astin JW; Crosier KE; Crosier PS; Hall CJ
    Zebrafish; 2019 Apr; 16(2):171-181. PubMed ID: 30724716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD68-expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen species.
    Pizzolla A; Gelderman KA; Hultqvist M; Vestberg M; Gustafsson K; Mattsson R; Holmdahl R
    Eur J Immunol; 2011 Feb; 41(2):403-12. PubMed ID: 21268010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
    Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class A.
    Rensen PC; Gras JC; Lindfors EK; van Dijk KW; Jukema JW; van Berkel TJ; Biessen EA
    Curr Drug Discov Technol; 2006 Jun; 3(2):135-44. PubMed ID: 16925521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages.
    Hattori Y; Yamashita J; Sakaida C; Kawano K; Yonemochi E
    J Liposome Res; 2015; 25(2):131-40. PubMed ID: 25203609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary effects of chronic exposure to liposome aerosols in mice.
    Myers MA; Thomas DA; Straub L; Soucy DW; Niven RW; Kaltenbach M; Hood CI; Schreier H; Gonzalez-Rothi RJ
    Exp Lung Res; 1993; 19(1):1-19. PubMed ID: 8440200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent.
    Lozano N; Al-Ahmady ZS; Beziere NS; Ntziachristos V; Kostarelos K
    Int J Pharm; 2015 Mar; 482(1-2):2-10. PubMed ID: 25445515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease.
    Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J
    Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model.
    Ekdawi SN; Stewart JM; Dunne M; Stapleton S; Mitsakakis N; Dou YN; Jaffray DA; Allen C
    J Control Release; 2015 Jun; 207():101-11. PubMed ID: 25862513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages.
    Tanaka Y; Kasai M; Taneichi M; Naito S; Kato H; Mori M; Nishida M; Maekawa N; Yamamura H; Komuro K; Uchida T
    Bioconjug Chem; 2004; 15(1):35-40. PubMed ID: 14733581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical and Preclinical Evaluation of Spermine-Derived Surfactant Liposomes for in Vitro and in Vivo siRNA-Delivery to Liver Macrophages.
    Müller LK; Kaps L; Schuppan D; Brose A; Chai W; Fischer K; Müller S; Frey H; Schmidt M; Mohr K
    Mol Pharm; 2016 Nov; 13(11):3636-3647. PubMed ID: 27700112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Fluorescence Imaging of Passive Inflammation Site Accumulation of Liposomes via Intravenous Administration Focused on Their Surface Charge and PEG Modification.
    Ibaraki H; Takeda A; Arima N; Hatakeyama N; Takashima Y; Seta Y; Kanazawa T
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33466905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease.
    Shi C; Dawulieti J; Shi F; Yang C; Qin Q; Shi T; Wang L; Hu H; Sun M; Ren L; Chen F; Zhao Y; Liu F; Li M; Mu L; Liu D; Shao D; Leong KW; She J
    Sci Adv; 2022 Jan; 8(4):eabj2372. PubMed ID: 35089791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.